Effects of bromocriptine for prolactin-secreting adenomas: analysis by CT scan.
Effects of bromocriptine on the size of adenomas in CT scans were examined in eight patients with prolactin-secreting adenomas. The changes on CT scans were classified into three types: Type I showed a reduction of enhanced area, Type II showed a decrease of enhanced density and Type III showed no change on CT scans.
D000236:Adenoma / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000378:metabolism*; D000328:Adult; D001971:Bromocriptine / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008793:Metrizamide; D008875:Middle Aged; D010911:Pituitary Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000378:metabolism*; D011388:Prolactin / Q000378:metabolism*; D014057:Tomography, X-Ray Computed
D001971:Bromocriptine; D011388:Prolactin; D008793:Metrizamide